Bristol-Myers Squibb Reaffirms FY22 Adj. EPS Outlook; Swings To Profit In Q4 - Quick Facts

While reporting financial results for the fourth quarter on Friday, biopharmaceutical company Bristol-Myers Squibb Co. (BMY) provided earnings, adjusted earnings and revenue guidance for the full-year 2022.

from RTT - Earnings https://ift.tt/1srpUXc
via IFTTT